Establishing bioequivalence is difficult for drugs with high inter-subject variability or strong dependence on the physiological state of the gut.
Nasir M. Idkaidek, Ph.D.
Advertisement
Articles by Nasir M. Idkaidek, Ph.D.
Advertisement
Latest Updated Articles
Gastric-State-Controlled Bioequivalence StudiesPublished: October 1st 2004 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
